Pre-Conference Planner
This pre-conference planner provides a comprehensive overview of all the relevant abstracts related to cancer vaccine. These abstracts are categorized separately by clinical trial, preclinical drug data, as well as therapeutic class, and abstracts under embargo.
Please note that some information has been removed from the downloadable content below. If you would like to receive the complete version and speak with one of our cancer vaccine specialists, please do not hesitate to contact beacon@hansonwade.com to discuss your drug development data needs.
Post-Conference Report
With the conclusion of SITC 2023, we are excited to bring you a detailed post-conference report that delves into a comprehensive abstract analysis and summary of the notable cancer vaccine-relevant abstracts uncovered during the meeting.
Explore the latest insights and advancements in the field as we break down key findings for a thorough understanding of the conference highlights.
Please note that some information has been removed from the downloadable content below. If you would like to receive the complete version and speak with one of our cancer vaccine specialists, please do not hesitate to contact beacon@hansonwade.com to discuss your drug development data needs.
Beacon Cancer Vaccine
How the most complete cancer vaccine database can help you
What we cover
Beacon Cancer Vaccine covers trial and drug records for clinical, preclinical, approved and discontinued prophylactic and therapeutic cancer vaccines. This database will cover ‘off the shelf’ and personalized approaches to:
Cellular Vaccines
Viral Vaccines
Bacterial Vaccines
Protein Vaccines
Yeast Vaccines
Peptide Vaccines
Nucleic Acid-Based Vaccines
How Beacon Cancer Vaccine works
Search the trial and drug landscape by antigen, vaccine type and adjuvant alongside other search criteria including disease, biomarker and sponsor to instantly extract the data points you need to conduct more complex analyses.
Our unique Milestones filter and visualization highlights past, present, and future drug development milestones including drug and trial readouts, asset history, and regulatory announcements. This enhancement provides an accurate, timely and exhaustive single-drug timeline allowing you to benchmark progress in the cancer vaccine space.
Find out more
Beacon is the essential decision-support tool for developers of complex therapeutics. Our market-defining, proprietary ontologies, combined with the most accurate and comprehensive life sciences data, provide our customers with unparalleled visibility of the drug and trial landscape.
With Beacon, you can make drug development decisions with confidence. This is why 23 of the world’s top 25 drug developers trust us.
At Beacon, we are committed to empowering our pharmaceutical and biotech industry partners with accurate, comprehensive data. We are not just a tool; we see ourselves as a partner in the drug development journey. Contact us to learn how we help you.
